AIMS: The Adherence to Refills and Medications Scale (ARMS) has been associated with objective measures of adherence and may address limitations of existing self-report measures of diabetes medication adherence. We modified the ARMS to specify adherence to diabetes medicines (ARMS-D), examined its psychometric properties, and compared its predictive validity with HbA1C against the most widely used self-report measure of diabetes medication adherence, the Summary of Diabetes Self-Care Activities medications subscale (SDSCA-MS). We also examined measurement differences by age (<65 vs. ≥65 years) and insulin status. METHODS: We administered self-report measures to 314 adult outpatients prescribed medications for type 2 diabetes and collected point-of-care HbA1C. RESULTS: One of the 12-item ARMS-D items was identified as less relevant to adherence to diabetes medications and removed. The 11-item ARMS-D had good internal consistency reliability (α=0.86), maintained its factor structure, and had convergent validity with the SDSCA-MS (rho=-0.52, p<0.001). Both the ARMS-D (β=0.16, p<0.01) and the SDSCA-MS (β=-0.12, p<0.05) independently predicted HbA1C after adjusting for covariates, but this association did not hold among participants ≥65 years in subgroup analyses. There were no differences in ARMS-D or SDSCA-MS scores by insulin status, but participants on insulin reported more problems with adherence on two ARMS-D items (i.e., feeling sick and medicine costs). CONCLUSIONS: The ARMS-D is a reliable and valid measure of diabetes medication adherence, and is more predictive of HbA1C than the SDSCA-MS, but takes more time to administer. The ARMS-D also identifies barriers to adherence, which may be useful in research and clinical practice.
AIMS: The Adherence to Refills and Medications Scale (ARMS) has been associated with objective measures of adherence and may address limitations of existing self-report measures of diabetes medication adherence. We modified the ARMS to specify adherence to diabetes medicines (ARMS-D), examined its psychometric properties, and compared its predictive validity with HbA1C against the most widely used self-report measure of diabetes medication adherence, the Summary of Diabetes Self-Care Activities medications subscale (SDSCA-MS). We also examined measurement differences by age (<65 vs. ≥65 years) and insulin status. METHODS: We administered self-report measures to 314 adult outpatients prescribed medications for type 2 diabetes and collected point-of-care HbA1C. RESULTS: One of the 12-item ARMS-D items was identified as less relevant to adherence to diabetes medications and removed. The 11-item ARMS-D had good internal consistency reliability (α=0.86), maintained its factor structure, and had convergent validity with the SDSCA-MS (rho=-0.52, p<0.001). Both the ARMS-D (β=0.16, p<0.01) and the SDSCA-MS (β=-0.12, p<0.05) independently predicted HbA1C after adjusting for covariates, but this association did not hold among participants ≥65 years in subgroup analyses. There were no differences in ARMS-D or SDSCA-MS scores by insulin status, but participants on insulin reported more problems with adherence on two ARMS-D items (i.e., feeling sick and medicine costs). CONCLUSIONS: The ARMS-D is a reliable and valid measure of diabetes medication adherence, and is more predictive of HbA1C than the SDSCA-MS, but takes more time to administer. The ARMS-D also identifies barriers to adherence, which may be useful in research and clinical practice.
Authors: Marya J Cohen; Shimon Shaykevich; Courtney Cawthon; Sunil Kripalani; Michael K Paasche-Orlow; Jeffrey L Schnipper Journal: J Hosp Med Date: 2012-04-02 Impact factor: 2.960
Authors: Richard A Hansen; Mimi M Kim; Liping Song; Wanzhu Tu; Jingwei Wu; Michael D Murray Journal: Ann Pharmacother Date: 2009-03-03 Impact factor: 3.154
Authors: Jeffrey S Gonzalez; Havah E Schneider; Deborah J Wexler; Christina Psaros; Linda M Delahanty; Enrico Cagliero; Steven A Safren Journal: Diabetes Care Date: 2012-11-30 Impact factor: 19.112
Authors: Leonard E Egede; Mulugeta Gebregziabher; Clara E Dismuke; Cheryl P Lynch; R Neal Axon; Yumin Zhao; Patrick D Mauldin Journal: Diabetes Care Date: 2012-08-21 Impact factor: 19.112
Authors: Lyndsay A Nelson; Michael T Ackerman; Robert A Greevy; Kenneth A Wallston; Lindsay S Mayberry Journal: Am J Prev Med Date: 2019-05-24 Impact factor: 5.043
Authors: Sunil Kripalani; Kathryn Goggins; Sam Nwosu; Jonathan Schildcrout; Amanda S Mixon; Candace McNaughton; Amanda M McDougald Scott; Kenneth A Wallston Journal: J Health Commun Date: 2015